Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
BioCardia ( (BCDA) ) just unveiled an announcement.
BioCardia, Inc. has announced that its 2025 Annual Meeting of Stockholders will take place on December 2, 2025, at 9:00 a.m. Pacific Time in Palo Alto, California. The company has set October 8, 2025, as the record date for stockholders eligible to vote and October 17, 2025, as the deadline for stockholder proposals and nominations for the meeting, in compliance with SEC regulations.
The most recent analyst rating on (BCDA) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on BioCardia stock, see the BCDA Stock Forecast page.
Spark’s Take on BCDA Stock
According to Spark, TipRanks’ AI Analyst, BCDA is a Neutral.
BioCardia’s overall stock score is primarily impacted by its weak financial performance and challenging valuation. While there are positive developments in clinical trials and regulatory pathways, the financial instability and bearish technical indicators weigh heavily on the score.
To see Spark’s full report on BCDA stock, click here.
More about BioCardia
Average Trading Volume: 726,434
Technical Sentiment Signal: Sell
Current Market Cap: $14.85M
See more insights into BCDA stock on TipRanks’ Stock Analysis page.